Drug intelligence / Profile preview

MGC0109

Development stage
Preclinical
Lead developer
Magnus Oxygen
Modality
Small Molecules
Administration
Injectable
01

Overview

**MGC0109** is an investigational **injectable small-molecule metabolic agent** being developed within the Magnus Charitable Trust portfolio, with Magnus Oxygen identified as the associated portfolio company. Publicly available pipeline information indicates that it is being explored for **ischemia-reperfusion related conditions**, including **ST-elevation myocardial infarction**, **reperfusion injury**, **chronic heart failure**, **stroke**, and **kidney transplant or kidney injury**. The precise molecular target and detailed pharmacology have not been publicly disclosed; based on the available description, the program appears intended for **metabolic modulation during ischemia-reperfusion injury** and may relate conceptually to **targeted temperature management** or tissue-protective metabolic support rather than a defined validated target.

Other names
TTM

Beyond the preview

Go deeper on MGC0109.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MGC0109.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call